<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/04045EDD-7ACE-4265-832A-5E359E4F6C60" ns1:id="04045EDD-7ACE-4265-832A-5E359E4F6C60"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/20B7E6D9-2EAE-472D-BBF4-0CF21B027571" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/D3045038-BC48-4879-B77D-185CA279893E" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/D3045038-BC48-4879-B77D-185CA279893E" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2021-02-28T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/BC81DFC3-C173-42D7-8495-9ED41B0E0FF6" ns1:rel="FUND" ns1:start="2020-05-31T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">61468</ns2:identifier></ns2:identifiers><ns2:title>Discovering Anti-Viral Treatments for COVID-19 Infections</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Feasibility Studies</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>COVID-19, caused by a novel coronavirus, has presented mankind with unprecedented challenges. In order to tackle this ongoing crisis, we require solutions which both **prevent** and **treat** infections.

We propose a high-throughput screen to discover compounds which exhibit antiviral properties against SARS-CoV-2, the novel coronavirus behind the current pandemic. Our library of over 100 natural-product producing organisms have already been shown as powerhouses of anti-infective production, and our proposal puts these compounds against SARS-CoV-2 in order to identify promising treatments.

--ADDITIONAL INFORMATION--

We will also undertake business development activities, taking our library of compounds to potential pharmaceutical partners for evaluation. In addition we will also evaluate our compounds against other targets beyond COVID-19 to fully exploit the materials we have produced.</ns2:abstractText></ns2:project>